Molecular pharmacology of GPCRs

Research output: Contribution to journalEditorialOther

3 Citations (Scopus)

Abstract

This themed section of the British Journal of Pharmacology stems from the ninth in the series of MPGPCR meetings, held as a joint initiative with the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists in Melbourne, Australia, from 28 to 30 November 2016. The articles provide insights into how GPCR environment can influence function, the identification of new drug targets based on allostery, biased agonism and oligomerization and the importance of taking into account sexual dimorphism in developing animal models for the evaluation of potential treatments for cardiovascular disease. In addition, novel approaches are presented for the treatment of metabolic disease, disturbances of calcium homeostasis and migraine.

Original languageEnglish
Pages (from-to)4005-4008
Number of pages4
JournalBritish Journal of Pharmacology
Volume175
Issue number21
DOIs
Publication statusPublished - 1 Nov 2018

Cite this